As of 2025-06-29, the EV/EBITDA ratio of Karuna Therapeutics Inc (KRTX) is -25.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KRTX's latest enterprise value is 12,397.18 mil USD. KRTX's TTM EBITDA according to its financial statements is -492.49 mil USD. Dividing these 2 quantities gives us the above KRTX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 12.6x | 12.2x |
| Forward P/E multiples | 16.2x - 30.7x | 19.5x |
| Fair Price | (204.52) - (157.79) | (199.74) |
| Upside | -162.0% - -147.8% | -160.6% |
| Date | EV/EBITDA |